Bacil Pharma Limited (BOM:524516)
India · Delayed Price · Currency is INR 50.03
-1.06 (-2.07%)
At close: May 29, 2026
Bacil Pharma Market Cap
Bacil Pharma has a market cap or net worth of 718.08 million as of June 1, 2026. Its market cap has increased by 111.22% in one year.
Market Cap
718.08M
Enterprise Value
712.40M
Revenue
n/a
Ranking
n/a
PE Ratio
83.51
Stock Price
50.03
Market Cap Chart
Since April 23, 2007, Bacil Pharma's market cap has increased from 21.80M to 718.08M, an increase of 3,193.78%. That is a compound annual growth rate of 20.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 718.08M | 40.38% |
| Dec 31, 2025 | 511.54M | 59.83% |
| Dec 31, 2024 | 320.06M | 751.72% |
| Dec 29, 2023 | 37.58M | -32.13% |
| Dec 23, 2022 | 55.37M | 31.47% |
| Dec 31, 2021 | 42.11M | 51.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Accretion Nutraveda | 1.89B |
| Auro Laboratories | 1.73B |
| Kimia Biosciences | 1.73B |
| Resonance Specialties | 1.46B |
| Smruthi Organics | 1.41B |
| Tyche Industries | 1.40B |
| Krebs Biochemicals & Industries | 1.39B |
| Vasundhara Rasayans | 473.23M |